Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

Saved in:
Bibliographic Details
Title: Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.
Authors: Biau J; Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France; Clermont Auvergne University, INSERM U1240 IMoST, Clermont-Ferrand, France., Beddok A; Department of Radiation Oncology, Institute Godinot, Reims, France; CRESTIC EA 3804, University of Reims Champagne-Ardenne, Reims, France. Electronic address: arnaud.beddok.mdphd@gmail.com., Sharma M; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Malik N; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ghosh Laskar S; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Cacicedo J; Department of Radiation Oncology, Cruces University Hospital, Biobizkaia Health Research Institute, Barakaldo, Spain., Embring A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Nuyts S; Department of Radiation Oncology, UZ Leuven, Leuven Cancer Institute, Leuven, Belgium., Mayo C; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Paradis KC; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Ward MC; Department of Radiation Oncology, Levine Cancer Institute, Advocate Health, Charlotte, NC, USA., Bonomo P; Department of Radiation Oncology, Careggi University Hospital, University of Florence, Florence, Italy., Gan GN; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Bahl A; Department of Radiation Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Balermpas P; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Chua MLK; Department of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore., Popovtzer A; Department of Radiation Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Simone CB 2nd; New York Proton Center, New York, NY, USA., Vasquez Osorio E; Division of Cancer Sciences, University of Manchester, Manchester, UK., Yom SS; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Blanchard P; INSERM U1018 CESP, University Paris-Saclay, Villejuif, France; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Corporate Authors: Reirradiation Collaborative Group (ReCOG) and ESTRO Reirradiation Focus Group Collaborators
Source: The Lancet. Oncology [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. e350-e361.
Publication Type: Journal Article; Consensus Statement; Review; Practice Guideline
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(26)00174-9